Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Multiple Contributors
The Society for Acupuncture Research (SAR), a 501(c)3 non-profit organization founded in 1993, moderates this column, with contributions from various authors. Its mission is “to advance patient by promoting scientific evaluation into acupuncture and allied therapies, as well as dissemination and implementation of these findings.” Other stated objectives include identifying the mechanisms underlying clinical effects; informing knowledge gaps and future research directions; and supporting the next generation of researchers, academic clinicians and educators. Learn more at https://www.acupunctureresearch.org.